CIK 0001906324
- Large accelerated filer
QuidelOrtho Corp
Sign in to watch- Ticker
- QDEL
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Jan 1
- Entity type
- Operating
- EIN
- 874496285
- Phone
- +1 858-552-1100
- Business address
- 9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
- Former names
- Coronado Topco, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-28 | Kroll Werner SVP, Research & Development | Grant or award | +1,170 | 36,951 | ||
| 2024-07-28 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −594 | $38.91 | $23K | 36,357 |
| 2024-07-28 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −1,170 | 0 | ||
| 2024-03-28 | Kroll Werner SVP, Research & Development | Grant or award | +3,811 | 37,582 | ||
| 2024-03-28 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −1,801 | $47.94 | $86K | 35,781 |
| 2024-03-28 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −3,811 | 7,622 | ||
| 2024-02-08 | Kroll Werner SVP, Research & Development | Grant or award · Restricted Stock Units | +14,920 | 14,920 | ||
| 2024-02-01 | Kroll Werner SVP, Research & Development | Grant or award | +1,313 | 34,451 | ||
| 2024-02-01 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −680 | $69.45 | $47K | 33,771 |
| 2024-02-01 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −1,313 | 0 | ||
| 2024-01-31 | Kroll Werner SVP, Research & Development | Grant or award | +3,628 | 33,343 | ||
| 2024-01-31 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −1,946 | $68.51 | $133K | 31,397 |
| 2024-01-31 | Kroll Werner SVP, Research & Development | Grant or award | +3,547 | 34,944 | ||
| 2024-01-31 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −1,806 | $68.51 | $124K | 33,138 |
| 2024-01-31 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −3,628 | 3,628 | ||
| 2024-01-31 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −3,547 | 3,548 | ||
| 2023-07-28 | Kroll Werner SVP, Research & Development | Grant or award | +1,170 | 30,188 | ||
| 2023-07-28 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −549 | $87.12 | $48K | 29,639 |
| 2023-07-28 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −1,170 | 1,170 | ||
| 2023-07-01 | Kroll Werner SVP, Research & Development | Grant or award | +981 | 29,236 |
Page 1 of 3 · 59 trades